3D-Arthro
Arthroplasty planning and patient-specific instrumentation
Software · Cloud SaaSCompany source
Company profile
About 3D-Side
AI-powered 3D preoperative planning and patient-specific medical devices for surgical workflow optimization and planning.
Company description 3D-Side official website
Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at 3D-Side?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- arthroplasty (knee, shoulder, ankle)
- bone tumors
- chondrosarcoma
- corrective osteotomy
- cranioplasty
- femoral neck osteotomy
- pelvic tumor resection
- periacetabular osteotomy
Who it serves
- Arthroplasty Implant Manufacturers
- Medical Device Companies
- Neurosurgeons
- Orthopedic Surgeons
- Patient-Specific Device Manufacturers
Deployment & integration
Cloud Saas · Hybrid deployment with recorded integration context.
Geographic context
MarketsBelgium · Europe · United States
Company sourceOfficial website
Company milestones
Platform expansion
510(k) clearance for shoulder and ankle arthroplasty (Customize for Arthroplasty). Multiple surgical case studies published in 2024-2025 demonstrating clinical applications across bone tumor resection, osteotomy, and arthroplasty procedures.
Partnerships
Recorded partners
- Children's Hospital of Philadelphia
- CHU Reims
- Integrated Shoulder Collaboration
- UCLouvain University
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
3D-Cut
Patient-specific cutting guides for bone tumor resection and corrective osteotomy
Device · HybridCompany source
3D-Skull
AI-powered cranioplasty solutions with patient-specific implants
Device · HybridCompany source
Customize
Web platform for personalized medical devices with AI automation
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Quality of resection margin with patient specific instrument for bone tumor resection.Journal of bone oncology · Jun 1, 2022
Patient-Specific Instruments for Forearm Sarcoma Resection and Allograft Reconstruction in Children: Results in 4 Cases.Sarcoma · Jan 1, 2022
Resection margins obtained with patient-specific instruments for resecting primary pelvic bone sarcomas: A case-control study.Orthopaedics & traumatology, surgery & research : OTSR · Jun 1, 2019
A Cadaveric Comparative Study on the Surgical Accuracy of Freehand, Computer Navigation, and Patient-Specific Instruments in Joint-Preserving Bone Tumor Resections.Sarcoma · Jan 1, 2018
Surgical navigation in paediatric orthopaedics.EFORT open reviews · May 1, 2016
Clinical validation
Clinical-trial records
Cost-effectiveness Evaluation of the Use of a Patient Specific Instrument for Surgical Resection of Malignant Bone Tumor Within the Pelvis Versus the Conventional Surgical TreatmentNCT02544711 · Mentioned · COMPLETED
Regulatory
Regulatory records
CustomizeK221432 · 510k · Aug 3, 2022
CustomizeK213779 · 510k · Mar 16, 2022
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
surgical precision
patient-specific cutting guides for bone tumor resection and osteotomies
workflow efficiency
streamlined preoperative planning to post-market surveillance
perfect fit and function
custom cranial implants with high quality and fast delivery
CHU Reims
Complex pelvic tumor resection with 3D planning and patient-specific guides
Children's Hospital of Philadelphia
Femoral neck osteotomy guided by four patient-specific instruments
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Laurent Paul
Founder & Co-CEO
Khanh Tran Duy
Founder & Co-CEO
Davide Bianchi
Board Chairman
Jean-Marie Berger
Board Member & President and CEO at Integrated
Nicolas Roberti de Winghe
Board Observer
Guido Van der Schueren
Board Member
Laurent Jouret
Board Member
Charles Nolet
Board Observer
06 · Company updates
Updates from 3D-Side
Recent articles published on 3D-Side's official website.
Bone Tumor Resection Planning: A Case of Maximum Bone Preservation
Read on 3D-SideWhen Accuracy and Certainty Are Not Enough on Their Own
Read on 3D-SideFemoral Neck Osteotomy: A Four-Guide System and What One of Them Taught Us
Read on 3D-SidePatient-Specific Guide for Corrective Osteotomy: Closing an Angle and a Rotation in One Move
Read on 3D-SideUnderstanding Total Knee Arthroplasty in Today’s Orthopedic Landscape
Read on 3D-Side07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Surgical AI & Robotics
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.